Identification of Specific Hemoglobin Adduct Patterns in Users of Different Tobacco/nicotine Products by Nontargeted GC–MS/MS Analysis

Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb) and albumin. New nicotine and tobacco products are discussed as less harmful forms of tobacco use compared to smoking combustible cigarettes...

Full description

Saved in:
Bibliographic Details
Published inChemical research in toxicology Vol. 37; no. 11; pp. 1884 - 1902
Main Authors Pilz, Fabian, Burkhardt, Therese, Scherer, Gerhard, Scherer, Max, Pluym, Nikola
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 18.11.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb) and albumin. New nicotine and tobacco products are discussed as less harmful forms of tobacco use compared to smoking combustible cigarettes (CC) due to reduced exposure to harmful constituents. Hence, the adduct profile in users of various tobacco/nicotine products is expected to differ characteristically. In this article, we present a novel nontargeted screening strategy using GC–MS/MS for Hb adducts based on the analysis of the respective derivatized N-terminal valine adducts after modified Edman degradation. We analyzed blood samples from a clinical study with habitual users of CCs, electronic cigarettes, heated tobacco products (HTPs), oral tobacco, nicotine replacement therapy products and nonusers of any tobacco/nicotine products. Our nontargeted approach revealed significant differences in the Hb adduct profiles of the investigated tobacco/nicotine product user groups. Adduct identification was performed by means of an internal database, retention time estimations based on the theoretical boiling points, as well as in-house synthesized reference compounds. Several chemicals that form adducts with Hb could be identified: methylating and ethylating agents, ethylene oxide, acrylonitrile, acrylamide, glycidamide and 4-hydroxybenzaldehyde. Levels were elevated in smokers compared to all other groups for Hb adducts from methylating agents, ethylene oxide, acrylonitrile, acrylamide and glycidamide. Our approach revealed higher concentrations of Hb adducts formed by ethylation, acrylamide and glycidamide in users of HTPs compared to nonusers. However, concentrations for the latter two were still lower than in smokers. Due to their long half-lives, Hb adducts related to acrylonitrile, acrylamide (glycidamide), and ethylene oxide exposure may be useful for the biochemical verification of subjects̀ compliance in longitudinal and cross-sectional studies with respect to smoking and HTP use/abstinence.
AbstractList Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb) and albumin. New nicotine and tobacco products are discussed as less harmful forms of tobacco use compared to smoking combustible cigarettes (CC) due to reduced exposure to harmful constituents. Hence, the adduct profile in users of various tobacco/nicotine products is expected to differ characteristically. In this article, we present a novel nontargeted screening strategy using GC-MS/MS for Hb adducts based on the analysis of the respective derivatized N-terminal valine adducts after modified Edman degradation. We analyzed blood samples from a clinical study with habitual users of CCs, electronic cigarettes, heated tobacco products (HTPs), oral tobacco, nicotine replacement therapy products and nonusers of any tobacco/nicotine products. Our nontargeted approach revealed significant differences in the Hb adduct profiles of the investigated tobacco/nicotine product user groups. Adduct identification was performed by means of an internal database, retention time estimations based on the theoretical boiling points, as well as in-house synthesized reference compounds. Several chemicals that form adducts with Hb could be identified: methylating and ethylating agents, ethylene oxide, acrylonitrile, acrylamide, glycidamide and 4-hydroxybenzaldehyde. Levels were elevated in smokers compared to all other groups for Hb adducts from methylating agents, ethylene oxide, acrylonitrile, acrylamide and glycidamide. Our approach revealed higher concentrations of Hb adducts formed by ethylation, acrylamide and glycidamide in users of HTPs compared to nonusers. However, concentrations for the latter two were still lower than in smokers. Due to their long half-lives, Hb adducts related to acrylonitrile, acrylamide (glycidamide), and ethylene oxide exposure may be useful for the biochemical verification of subjects̀ compliance in longitudinal and cross-sectional studies with respect to smoking and HTP use/abstinence.
Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb) and albumin. New nicotine and tobacco products are discussed as less harmful forms of tobacco use compared to smoking combustible cigarettes (CC) due to reduced exposure to harmful constituents. Hence, the adduct profile in users of various tobacco/nicotine products is expected to differ characteristically. In this article, we present a novel nontargeted screening strategy using GC-MS/MS for Hb adducts based on the analysis of the respective derivatized N-terminal valine adducts after modified Edman degradation. We analyzed blood samples from a clinical study with habitual users of CCs, electronic cigarettes, heated tobacco products (HTPs), oral tobacco, nicotine replacement therapy products and nonusers of any tobacco/nicotine products. Our nontargeted approach revealed significant differences in the Hb adduct profiles of the investigated tobacco/nicotine product user groups. Adduct identification was performed by means of an internal database, retention time estimations based on the theoretical boiling points, as well as in-house synthesized reference compounds. Several chemicals that form adducts with Hb could be identified: methylating and ethylating agents, ethylene oxide, acrylonitrile, acrylamide, glycidamide and 4-hydroxybenzaldehyde. Levels were elevated in smokers compared to all other groups for Hb adducts from methylating agents, ethylene oxide, acrylonitrile, acrylamide and glycidamide. Our approach revealed higher concentrations of Hb adducts formed by ethylation, acrylamide and glycidamide in users of HTPs compared to nonusers. However, concentrations for the latter two were still lower than in smokers. Due to their long half-lives, Hb adducts related to acrylonitrile, acrylamide (glycidamide), and ethylene oxide exposure may be useful for the biochemical verification of subjects̀ compliance in longitudinal and cross-sectional studies with respect to smoking and HTP use/abstinence.Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb) and albumin. New nicotine and tobacco products are discussed as less harmful forms of tobacco use compared to smoking combustible cigarettes (CC) due to reduced exposure to harmful constituents. Hence, the adduct profile in users of various tobacco/nicotine products is expected to differ characteristically. In this article, we present a novel nontargeted screening strategy using GC-MS/MS for Hb adducts based on the analysis of the respective derivatized N-terminal valine adducts after modified Edman degradation. We analyzed blood samples from a clinical study with habitual users of CCs, electronic cigarettes, heated tobacco products (HTPs), oral tobacco, nicotine replacement therapy products and nonusers of any tobacco/nicotine products. Our nontargeted approach revealed significant differences in the Hb adduct profiles of the investigated tobacco/nicotine product user groups. Adduct identification was performed by means of an internal database, retention time estimations based on the theoretical boiling points, as well as in-house synthesized reference compounds. Several chemicals that form adducts with Hb could be identified: methylating and ethylating agents, ethylene oxide, acrylonitrile, acrylamide, glycidamide and 4-hydroxybenzaldehyde. Levels were elevated in smokers compared to all other groups for Hb adducts from methylating agents, ethylene oxide, acrylonitrile, acrylamide and glycidamide. Our approach revealed higher concentrations of Hb adducts formed by ethylation, acrylamide and glycidamide in users of HTPs compared to nonusers. However, concentrations for the latter two were still lower than in smokers. Due to their long half-lives, Hb adducts related to acrylonitrile, acrylamide (glycidamide), and ethylene oxide exposure may be useful for the biochemical verification of subjects̀ compliance in longitudinal and cross-sectional studies with respect to smoking and HTP use/abstinence.
Author Scherer, Max
Burkhardt, Therese
Pilz, Fabian
Scherer, Gerhard
Pluym, Nikola
AuthorAffiliation ABF, Analytisch-Biologisches Forschungslabor GmbH
AuthorAffiliation_xml – name: ABF, Analytisch-Biologisches Forschungslabor GmbH
Author_xml – sequence: 1
  givenname: Fabian
  surname: Pilz
  fullname: Pilz, Fabian
– sequence: 2
  givenname: Therese
  surname: Burkhardt
  fullname: Burkhardt, Therese
– sequence: 3
  givenname: Gerhard
  orcidid: 0000-0001-7456-3402
  surname: Scherer
  fullname: Scherer, Gerhard
– sequence: 4
  givenname: Max
  surname: Scherer
  fullname: Scherer, Max
– sequence: 5
  givenname: Nikola
  orcidid: 0000-0003-4954-591X
  surname: Pluym
  fullname: Pluym, Nikola
  email: nikola.pluym@abf-lab.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39405427$$D View this record in MEDLINE/PubMed
BookMark eNqFkbFu2zAQhokiReMkfYWAYxfZPJKypNFw2yRAkgZwAnQTKOqUMpBIl6SAesuYvW_YJwkFu-2Y6YC777vh_0_IkXUWCTkHNgfGYaF0mOsfOHgM0f2aS80Yz8t3ZAY5Z1nOgB2RGSsrkXFefj8mJyE8MQbJLT6QY1FJlktezMjLVYs2ms5oFY2z1HV0s0U9LeglDu6xd42xdNW2o470TsWI3gaaVg8BfZj4z6br0Kcv9N41Smu3sEa7aCzSO-8mL9BmR2-djco_YsSWXqz_PP--2SxuNnRlVb8LJpyR953qA348zFPy8PXL_foyu_52cbVeXWdKMIhZIzTKCrqKS8WAc1bKtlEgsMyhlbJZ6gJ0p5dSLEFUPK-gZaKQUgOCKlQnTsmn_d-tdz_HlF49mKCx75VFN4ZaABSs4BWHhJ4f0LEZsK233gzK7-q_6SVguQe0dyF47P4hwOqppjrVVP-vqT7UlES-F6f7kxt9CiG8Jb0Cy6-ctQ
Cites_doi 10.1021/acs.chemrestox.8b00173
10.1006/abio.1996.0322
10.1016/B978-0-12-818158-4.00008-X
10.1093/toxsci/kfi307
10.1017/S002966510800712X
10.1155/2009/153472
10.1021/acs.chemrestox.2c00020
10.1021/tx000247+
10.1021/tx7002068
10.1158/1055-9965.EPI-05-0456
10.1016/S0021-9258(19)62688-8
10.1016/j.mrgentox.2004.10.013
10.1021/acs.chemrestox.7b00234
10.1016/j.fct.2016.03.028
10.3390/separations8100171
10.21105/joss.01686
10.1016/j.jchromb.2006.06.003
10.1016/0003-2697(86)90524-5
10.2478/cttr-2013-0668
10.1016/j.mrfmmm.2005.05.004
10.1078/1438-4639-00324
10.3389/fonc.2022.925743
10.1016/j.jchromb.2018.03.048
10.1111/bcpt.13393
10.1016/j.addbeh.2013.11.002
10.1093/carcin/12.2.257
10.1016/j.envint.2020.105545
10.1038/s41598-017-05930-9
10.1007/s00216-022-04143-y
10.1111/bcpt.12715
10.1021/tx5002749
10.1016/j.toxlet.2017.07.896
10.1016/j.mrgentox.2004.10.012
10.1016/j.jchromb.2010.03.034
10.1007/s00204-021-03165-2
10.1016/j.jchromb.2009.11.043
10.1038/nrc1190
10.1007/s10654-020-00625-4
10.1016/j.envres.2021.112659
10.1021/acs.estlett.1c00648
10.1021/cr300391r
10.1016/j.chroma.2007.07.044
10.1016/j.fochx.2022.100538
10.1021/tx9501041
10.1021/acs.chemrestox.7b00114
10.1124/dmd.105.006387
10.1021/acs.chemrestox.5b00287
10.1016/0165-1218(88)90046-8
10.1039/C8NP00074C
10.1016/S1470-2045(08)70173-6
10.1046/j.1440-1843.2003.00507.x
10.1016/j.crtox.2022.100067
10.1016/j.sjbs.2023.103704
10.9734/BJMMR/2015/16285
10.1093/carcin/9.6.875
10.1016/j.fct.2012.07.058
10.3390/ht8010006
10.1016/0076-6879(94)31045-9
10.1073/pnas.68.1.160
10.1007/978-3-319-67903-7_1
10.1186/1477-7517-8-11
10.1021/acs.chemrestox.2c00262
10.1093/carcin/23.12.2081
10.1016/j.toxrep.2019.05.009
10.1289/ehp.99-1567046
10.1080/10937404.2020.1852988
10.1016/j.conctc.2021.100794
10.1016/S1570-0232(02)00172-1
10.1002/rcm.8509
10.1021/tx4004352
10.1136/tc.2007.024158
10.2478/cttr-2021-0014
10.1007/s004200050353
10.1093/ije/dyr236
10.1021/acs.chemrestox.1c00111
10.1016/S0278-6915(00)00093-4
10.1007/s002040100235
10.1080/02772248609357133
10.3390/metabo12020154
10.1186/1471-2105-11-395
10.1093/toxsci/kfm091
10.3891/acta.chem.scand.40b-0453
10.1016/j.talanta.2020.121339
10.1016/j.fct.2012.04.004
10.1016/j.talanta.2017.09.092
10.1093/carcin/10.11.2123
10.1007/s11356-021-15444-7
10.1373/clinchem.2005.061408
10.1021/jf020302f
10.1016/0009-2797(92)90016-E
10.3390/toxics7010007
10.1007/s11356-022-23782-3
10.1002/jms.3083
10.1002/dta.3372
10.1016/0009-2797(95)03632-V
10.1021/tx700235t
10.1021/acs.jafc.5b02622
10.1093/carcin/7.9.1519
10.1016/j.fct.2021.112799
10.1183/16000617.0034-2016
10.1371/journal.pone.0154387
10.1038/s41370-023-00574-6
10.1007/s00204-018-2373-y
10.1002/em.21824
10.1093/carcin/23.11.1903
10.1021/acs.chemrestox.0c00092
10.1016/S0140-6736(20)30752-2
10.1007/s00204-022-03349-4
10.1289/ehp.1308015
10.1021/acs.chemrestox.6b00463
10.1021/tx960113p
10.1021/acs.chemrestox.6b00366
ContentType Journal Article
Copyright 2024 The Authors. Published by American Chemical Society
Copyright_xml – notice: 2024 The Authors. Published by American Chemical Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1021/acs.chemrestox.4c00258
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 1520-5010
EndPage 1902
ExternalDocumentID 39405427
10_1021_acs_chemrestox_4c00258
a294777810
Genre Journal Article
GroupedDBID ---
-~X
29B
4.4
55A
5GY
5RE
5VS
7~N
AABXI
ABJNI
ABMVS
ABQRX
ABUCX
ACGFS
ACJ
ACS
ADHLV
AEESW
AENEX
AFEFF
AGXLV
AHGAQ
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
CS3
CUPRZ
EBS
ED~
F5P
GGK
GNL
IH9
IHE
JG~
LG6
P2P
ROL
TN5
UI2
UPT
VF5
VG9
W1F
YZZ
AAYXX
ABBLG
ABLBI
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-a301t-b3ce491f924a0122084dba13e851d44b6c71cfc64361392591d03744c1e1a7af3
IEDL.DBID ACS
ISSN 0893-228X
1520-5010
IngestDate Fri Jul 11 06:04:05 EDT 2025
Mon Jul 21 05:59:31 EDT 2025
Tue Jul 01 03:37:37 EDT 2025
Tue Nov 19 03:21:03 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License https://doi.org/10.15223/policy-029
https://doi.org/10.15223/policy-037
https://doi.org/10.15223/policy-045
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a301t-b3ce491f924a0122084dba13e851d44b6c71cfc64361392591d03744c1e1a7af3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7456-3402
0000-0003-4954-591X
PMID 39405427
PQID 3117072921
PQPubID 23479
PageCount 19
ParticipantIDs proquest_miscellaneous_3117072921
pubmed_primary_39405427
crossref_primary_10_1021_acs_chemrestox_4c00258
acs_journals_10_1021_acs_chemrestox_4c00258
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-11-18
PublicationDateYYYYMMDD 2024-11-18
PublicationDate_xml – month: 11
  year: 2024
  text: 2024-11-18
  day: 18
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Chemical research in toxicology
PublicationTitleAlternate Chem. Res. Toxicol
PublicationYear 2024
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref45/cit45
ref99/cit99
ref3/cit3
ref81/cit81
ref16/cit16
ref52/cit52
ref114/cit114
ref23/cit23
ref115/cit115
ref116/cit116
ref110/cit110
ref111/cit111
ref2/cit2
ref112/cit112
ref77/cit77
ref113/cit113
ref71/cit71
ref117/cit117
ref20/cit20
ref48/cit48
ref118/cit118
ref74/cit74
ref35/cit35
ref89/cit89
ref19/cit19
ref93/cit93
ref96/cit96
International Agency for Research on Cancer (ref86/cit86) 2022
ref107/cit107
ref120/cit120
ref109/cit109
ref13/cit13
ref122/cit122
ref105/cit105
ref61/cit61
ref67/cit67
ref38/cit38
ref128/cit128
ref90/cit90
ref124/cit124
ref64/cit64
ref126/cit126
ref54/cit54
ref6/cit6
ref18/cit18
ref65/cit65
ref97/cit97
ref101/cit101
ref11/cit11
ref102/cit102
ref29/cit29
Stanfill S. B. (ref119/cit119) 2020
ref76/cit76
ref32/cit32
ref39/cit39
Van Sittert N. (ref42/cit42) 2002
ref43/cit43
ref80/cit80
ref133/cit133
ref28/cit28
ref132/cit132
ref91/cit91
ref55/cit55
ref12/cit12
ref66/cit66
ref22/cit22
ref121/cit121
ref33/cit33
ref87/cit87
ref106/cit106
ref129/cit129
ref44/cit44
World Health Organization (ref4/cit4) 2015; 989
ref70/cit70
ref125/cit125
ref9/cit9
ref27/cit27
ref63/cit63
Baker R. R. (ref98/cit98) 1999
ref56/cit56
ref8/cit8
ref31/cit31
ref59/cit59
ref85/cit85
ref34/cit34
ref37/cit37
Komsta L. (ref49/cit49) 2011
ref60/cit60
ref88/cit88
ref17/cit17
ref82/cit82
ref53/cit53
ref21/cit21
International Agency for Research on Cancer (ref7/cit7) 1985; 37
ref46/cit46
Gallage N. J. (ref108/cit108) 2018
R Core Team (ref50/cit50) 2023
ref24/cit24
ref78/cit78
ref36/cit36
ref83/cit83
ref79/cit79
ref100/cit100
ref25/cit25
ref103/cit103
ref72/cit72
ref14/cit14
ref57/cit57
Lewalter J. (ref123/cit123) 2002
World Health Organization (ref10/cit10) 2021
US Food and Drug Administration (ref5/cit5) 2012; 77
ref40/cit40
ref68/cit68
Rodgman A. (ref75/cit75) 2013
ref94/cit94
ref130/cit130
ref131/cit131
RStudio Team (ref51/cit51) 2023
ref26/cit26
ref73/cit73
ref69/cit69
ref15/cit15
ref62/cit62
ref41/cit41
ref58/cit58
ref95/cit95
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (ref92/cit92) 1999; 71
ref104/cit104
ref30/cit30
ref47/cit47
ref84/cit84
ref127/cit127
ref1/cit1
References_xml – ident: ref36/cit36
  doi: 10.1021/acs.chemrestox.8b00173
– ident: ref61/cit61
  doi: 10.1006/abio.1996.0322
– start-page: 167
  volume-title: Smokeless Tobacco Products
  year: 2020
  ident: ref119/cit119
  doi: 10.1016/B978-0-12-818158-4.00008-X
– volume: 989
  volume-title: WHO Study Group on Tobacco Product Regulation: Report on the Scientific Basis of Tobacco Product Regulation: Fifth Report of a WHO Study Group
  year: 2015
  ident: ref4/cit4
– volume-title: World Agriculture Series
  year: 1999
  ident: ref98/cit98
– ident: ref102/cit102
  doi: 10.1093/toxsci/kfi307
– ident: ref17/cit17
  doi: 10.1017/S002966510800712X
– ident: ref37/cit37
  doi: 10.1155/2009/153472
– ident: ref44/cit44
  doi: 10.1021/acs.chemrestox.2c00020
– ident: ref32/cit32
  doi: 10.1021/tx000247+
– volume-title: Package “Outliers”
  year: 2011
  ident: ref49/cit49
– ident: ref80/cit80
  doi: 10.1021/tx7002068
– ident: ref20/cit20
  doi: 10.1158/1055-9965.EPI-05-0456
– ident: ref81/cit81
  doi: 10.1016/S0021-9258(19)62688-8
– ident: ref38/cit38
  doi: 10.1155/2009/153472
– ident: ref104/cit104
  doi: 10.1016/j.mrgentox.2004.10.013
– start-page: 1
  volume-title: The MAK-Collection for Occupational Health and Safety: Annual Thresholds and Classifications for the Workplace
  year: 2002
  ident: ref42/cit42
– ident: ref77/cit77
  doi: 10.1021/acs.chemrestox.7b00234
– ident: ref33/cit33
  doi: 10.1016/j.fct.2016.03.028
– ident: ref47/cit47
  doi: 10.3390/separations8100171
– ident: ref52/cit52
  doi: 10.21105/joss.01686
– ident: ref59/cit59
  doi: 10.1016/j.jchromb.2006.06.003
– ident: ref30/cit30
  doi: 10.1016/0003-2697(86)90524-5
– ident: ref2/cit2
  doi: 10.2478/cttr-2013-0668
– ident: ref101/cit101
  doi: 10.1016/j.mrfmmm.2005.05.004
– ident: ref100/cit100
  doi: 10.1078/1438-4639-00324
– ident: ref112/cit112
  doi: 10.3389/fonc.2022.925743
– ident: ref63/cit63
  doi: 10.1016/j.jchromb.2018.03.048
– ident: ref99/cit99
  doi: 10.1111/bcpt.13393
– ident: ref9/cit9
  doi: 10.1016/j.addbeh.2013.11.002
– ident: ref72/cit72
  doi: 10.1093/carcin/12.2.257
– ident: ref133/cit133
  doi: 10.1016/j.envint.2020.105545
– ident: ref91/cit91
  doi: 10.1038/s41598-017-05930-9
– ident: ref122/cit122
  doi: 10.1007/s00216-022-04143-y
– ident: ref93/cit93
  doi: 10.1111/bcpt.12715
– ident: ref34/cit34
  doi: 10.1021/tx5002749
– ident: ref53/cit53
– ident: ref89/cit89
  doi: 10.1016/j.toxlet.2017.07.896
– ident: ref103/cit103
  doi: 10.1016/j.mrgentox.2004.10.012
– ident: ref31/cit31
  doi: 10.1016/j.jchromb.2010.03.034
– volume-title: R: A Language and Environment for Statistical Computing
  year: 2023
  ident: ref50/cit50
– ident: ref54/cit54
– ident: ref124/cit124
  doi: 10.1007/s00204-021-03165-2
– ident: ref60/cit60
  doi: 10.1016/j.jchromb.2009.11.043
– ident: ref19/cit19
  doi: 10.1038/nrc1190
– ident: ref23/cit23
  doi: 10.1007/s10654-020-00625-4
– ident: ref97/cit97
  doi: 10.1016/j.envres.2021.112659
– ident: ref14/cit14
  doi: 10.1021/acs.estlett.1c00648
– ident: ref24/cit24
  doi: 10.1021/cr300391r
– ident: ref105/cit105
  doi: 10.1016/j.chroma.2007.07.044
– ident: ref68/cit68
  doi: 10.1016/j.fochx.2022.100538
– ident: ref79/cit79
  doi: 10.1021/tx9501041
– ident: ref74/cit74
  doi: 10.1021/acs.chemrestox.7b00114
– ident: ref109/cit109
  doi: 10.1124/dmd.105.006387
– ident: ref125/cit125
  doi: 10.1021/acs.chemrestox.5b00287
– ident: ref69/cit69
  doi: 10.1016/0165-1218(88)90046-8
– volume: 37
  start-page: 1
  year: 1985
  ident: ref7/cit7
  publication-title: IARC Monogr. Eval. Carcinog. Risks Hum.
– ident: ref110/cit110
  doi: 10.1039/C8NP00074C
– ident: ref111/cit111
  doi: 10.1016/S1470-2045(08)70173-6
– ident: ref113/cit113
  doi: 10.1046/j.1440-1843.2003.00507.x
– volume-title: IARC Monographs on the Evaluation of Carcinogenic Risks to Human
  year: 2022
  ident: ref86/cit86
– ident: ref46/cit46
  doi: 10.1016/j.crtox.2022.100067
– ident: ref116/cit116
  doi: 10.1016/j.sjbs.2023.103704
– ident: ref8/cit8
  doi: 10.9734/BJMMR/2015/16285
– ident: ref71/cit71
  doi: 10.1093/carcin/9.6.875
– ident: ref127/cit127
  doi: 10.1016/j.fct.2012.07.058
– volume: 77
  start-page: 20034
  year: 2012
  ident: ref5/cit5
  publication-title: Fed. Regist.
– ident: ref28/cit28
  doi: 10.3390/ht8010006
– ident: ref64/cit64
  doi: 10.1016/0076-6879(94)31045-9
– ident: ref11/cit11
  doi: 10.1073/pnas.68.1.160
– ident: ref55/cit55
– start-page: 3
  volume-title: Biotechnology of Natural Products
  year: 2018
  ident: ref108/cit108
  doi: 10.1007/978-3-319-67903-7_1
– ident: ref118/cit118
  doi: 10.1186/1477-7517-8-11
– ident: ref84/cit84
  doi: 10.1021/acs.chemrestox.2c00262
– ident: ref78/cit78
  doi: 10.1093/carcin/23.12.2081
– ident: ref117/cit117
  doi: 10.1016/j.toxrep.2019.05.009
– ident: ref120/cit120
– ident: ref58/cit58
  doi: 10.1289/ehp.99-1567046
– ident: ref90/cit90
  doi: 10.1080/10937404.2020.1852988
– ident: ref41/cit41
  doi: 10.1016/j.conctc.2021.100794
– ident: ref27/cit27
  doi: 10.1016/S1570-0232(02)00172-1
– ident: ref131/cit131
  doi: 10.1002/rcm.8509
– ident: ref25/cit25
  doi: 10.1021/tx4004352
– volume-title: The Chemical Components of Tobacco and Tobacco Smoke
  year: 2013
  ident: ref75/cit75
– ident: ref3/cit3
  doi: 10.1136/tc.2007.024158
– ident: ref1/cit1
  doi: 10.2478/cttr-2021-0014
– ident: ref121/cit121
  doi: 10.1007/s004200050353
– ident: ref21/cit21
  doi: 10.1093/ije/dyr236
– ident: ref107/cit107
  doi: 10.1021/acs.chemrestox.1c00111
– ident: ref65/cit65
  doi: 10.1016/S0278-6915(00)00093-4
– ident: ref73/cit73
  doi: 10.1007/s002040100235
– ident: ref29/cit29
  doi: 10.1080/02772248609357133
– ident: ref16/cit16
  doi: 10.3390/metabo12020154
– volume-title: WHO Report on the Global Tobacco Epidemic, 2021: Addressing New and Emerging Products
  year: 2021
  ident: ref10/cit10
– ident: ref48/cit48
  doi: 10.1186/1471-2105-11-395
– ident: ref106/cit106
  doi: 10.1093/toxsci/kfm091
– ident: ref130/cit130
  doi: 10.3891/acta.chem.scand.40b-0453
– ident: ref39/cit39
  doi: 10.1016/j.talanta.2020.121339
– ident: ref96/cit96
  doi: 10.1016/j.fct.2012.04.004
– ident: ref62/cit62
  doi: 10.1016/j.talanta.2017.09.092
– ident: ref66/cit66
  doi: 10.1093/carcin/10.11.2123
– ident: ref87/cit87
  doi: 10.1007/s11356-021-15444-7
– ident: ref12/cit12
  doi: 10.1373/clinchem.2005.061408
– ident: ref67/cit67
– ident: ref95/cit95
  doi: 10.1021/jf020302f
– ident: ref56/cit56
– ident: ref70/cit70
  doi: 10.1016/0009-2797(92)90016-E
– ident: ref128/cit128
  doi: 10.3390/toxics7010007
– ident: ref57/cit57
– ident: ref88/cit88
  doi: 10.1007/s11356-022-23782-3
– ident: ref114/cit114
  doi: 10.1002/jms.3083
– volume-title: RStudio: Integrated Development Environment for R
  year: 2023
  ident: ref51/cit51
– ident: ref45/cit45
  doi: 10.1002/dta.3372
– ident: ref82/cit82
  doi: 10.1016/0009-2797(95)03632-V
– ident: ref13/cit13
  doi: 10.1021/tx700235t
– ident: ref115/cit115
  doi: 10.1021/acs.jafc.5b02622
– ident: ref85/cit85
  doi: 10.1093/carcin/7.9.1519
– ident: ref94/cit94
  doi: 10.1016/j.fct.2021.112799
– ident: ref22/cit22
  doi: 10.1183/16000617.0034-2016
– ident: ref15/cit15
  doi: 10.1371/journal.pone.0154387
– ident: ref40/cit40
  doi: 10.1038/s41370-023-00574-6
– start-page: 35
  volume-title: The MAK-Collection for Occupational Health and Safety: Annual Thresholds and Classifications for the Workplace
  year: 2002
  ident: ref123/cit123
– ident: ref126/cit126
  doi: 10.1007/s00204-018-2373-y
– ident: ref83/cit83
  doi: 10.1002/em.21824
– ident: ref76/cit76
  doi: 10.1093/carcin/23.11.1903
– volume: 71
  volume-title: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
  year: 1999
  ident: ref92/cit92
– ident: ref132/cit132
  doi: 10.1021/acs.chemrestox.0c00092
– ident: ref6/cit6
  doi: 10.1016/S0140-6736(20)30752-2
– ident: ref43/cit43
  doi: 10.1007/s00204-022-03349-4
– ident: ref18/cit18
  doi: 10.1289/ehp.1308015
– ident: ref35/cit35
  doi: 10.1021/acs.chemrestox.6b00463
– ident: ref129/cit129
  doi: 10.1021/tx960113p
– ident: ref26/cit26
  doi: 10.1021/acs.chemrestox.6b00366
SSID ssj0011027
Score 2.4474525
Snippet Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb)...
SourceID proquest
pubmed
crossref
acs
SourceType Aggregation Database
Index Database
Publisher
StartPage 1884
SubjectTerms Adult
Electronic Nicotine Delivery Systems
Female
Gas Chromatography-Mass Spectrometry
Hemoglobins - analysis
Hemoglobins - chemistry
Hemoglobins - metabolism
Humans
Male
Middle Aged
Nicotine - analysis
Nicotine - blood
Nicotine - chemistry
Nicotine - metabolism
Tandem Mass Spectrometry
Tobacco Products - analysis
Title Identification of Specific Hemoglobin Adduct Patterns in Users of Different Tobacco/nicotine Products by Nontargeted GC–MS/MS Analysis
URI http://dx.doi.org/10.1021/acs.chemrestox.4c00258
https://www.ncbi.nlm.nih.gov/pubmed/39405427
https://www.proquest.com/docview/3117072921
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwEB4tywUJ8Vhe5SUjob2waWvHeR2rwrJC6qqordRb5PihRWgTRFKJcuLInX_IL2EmTrZCqAKulm0l9tjz2ePvG4CXsXZZhH4isGERBVIVOsjSyAVSWGMyqUIbEt95dh6freS7dbQ-gPGeCL7gI6Vx8C_sJaWqqL4MpSY3nV6D6yJOEzpuTaaLq7gBtvDanlkYCJGue07w3n7IKen6d6e0B2m2Huf0NrzveTv-ocnH4aYphvrrnzKO__wzd-BWBz_ZxNvLXTiw5REcz71-9faELXd0rPqEHbP5Ttl6ewQ3_SUf89yle_Dd03xdd-_HKsfafPaurXNZkdrIh5JNDInKsnkr5VnWDItWRPKk-q-7BC0NW-LOonU1KtE2G8S-bO7FaGtWbNl5Vfo369awt9Of337MFqPZgvWSKvdhdfpmOT0LutQOgcIdpQmKUFuZcYenP0XBvXEqTaF4aBEAGimLWCdcO41wCeFGhkc0bkgoR2puuUqUCx_AYVmV9hEwRTWizAjnnEzHWmmTODVWmoR2slgO4BWOet4tzTpvo-6C51S4m4q8m4oBjHpLyD95vY-_tnjRG0yOS5PiLaq01abOQ8rqg4cXwQfw0FvSVZ-UkD6SInn8X1_3BG4IBFXEheTpUzhsPm_sMwRFTfG8XQe_AN6EDKU
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwEB3BcgBptcACS_k0EtoLm7Z2nDY5VoWlwLaq1FbqLXL8IaHVJiuSSltOHLnzD_klzMRpK5BWCK6WY9nx2PPs8XsD8LqnXRKhnwhsmEWBVJkOkjhygRTWmESq0IbEdx5PeqOF_LiMls3VBXFhsBMltlTWQfydugDvUBkO44IyVhRXbanJW8c34RYiEkGnrsFwtg0f4Bde4jMJAyHi5YYafG075Jt0-btvugZw1o7n9C4st12u35uct1dV1tZf_1Bz_I8x3YODBoyygbee-3DD5odwPPVq1usTNt-Rs8oTdsymO53r9SHs-ys_5plMD-C7J_265haQFY7V2e1dXeeiIO2RzzkbGJKYZdNa2DMvGRYtiPJJ9d826VoqNsd9Ruuik6OlVoiE2dRL05YsW7NJkfsX7Naw98Of336MZ53xjG0EVh7C4vTdfDgKmkQPgcL9pQqyUFuZcIdnQUWhvm4sTaZ4aBEOGimznu5z7TSCJwQfCR7YuCHZHKm55aqvXPgI9vIit4-BKaoRJUY452Tc1UqbvlNdpUl2J-nJFrzBv542C7VM6xi84CkV7qYibaaiBZ2NQaSXXv3jr1-82thNiguVoi8qt8WqTEPK8YNHGcFbcOQNatsmpaePpOg_-afevYTbo_n4LD37MPn0FO4IhFvEkuTxM9irvqzsc4RLVfaiXhq_AO66FQY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEB62WyiF0sf2lT5VKHvpOolsObHpKWSbbh8JhiSQQ8HIesCyrL3UDjQ99dh7_2F_SWcsO6GFpbRXIQvJmtF8o9F8A_ByoGwcop3wTJCFnpCZ8uIotJ7wjdaxkIEJKN95OhucLMX7Vbjag9dtLgxOosSRyjqIT1p9oW3DMMB71I5LOaeqFcWXrlBksaMrcJVid-R5jcbzbQgBv3A0n3Hg-X60atODLx2H7JMqf7dPl4DO2vhMbsGn7bTrNydn3XWVddXXPxgd_3Ndt-FmA0rZyEnRHdgz-QEcJo7VenPEFrskrfKIHbJkx3e9OYAb7uqPuYymu_DdJf_a5jaQFZbVVe5t3ee8IA6S05yNNFHNsqQm-MxLhk1LSv2k_sdN2ZaKLfC8Uaro5SixFSJiljiK2pJlGzYrcveS3Wj2dvzz24_pvDeds5Zo5R4sJ28W4xOvKfjgSTxnKi8LlBExt-gTSgr59SOhM8kDg7BQC5EN1JArqxBEIQiJ0XHjmuhzhOKGy6G0wX3Yz4vcPAQmqUcYa99aK6K-kkoPrexLRfQ78UB04BX-9bRR2DKtY_E-T6lxtxVpsxUd6LVCkV44FpC_fvGilZ0UFZaiMDI3xbpMA6r1gy6NzzvwwAnVdkwqUx8Kf_jon2b3HK4lx5P047vZh8dw3UfURcmSPHoC-9XntXmKqKnKntXa8QuzeReJ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+Specific+Hemoglobin+Adduct+Patterns+in+Users+of+Different+Tobacco%2Fnicotine+Products+by+Nontargeted+GC-MS%2FMS+Analysis&rft.jtitle=Chemical+research+in+toxicology&rft.au=Pilz%2C+Fabian&rft.au=Burkhardt%2C+Therese&rft.au=Scherer%2C+Gerhard&rft.au=Scherer%2C+Max&rft.date=2024-11-18&rft.issn=1520-5010&rft.eissn=1520-5010&rft.volume=37&rft.issue=11&rft.spage=1884&rft_id=info:doi/10.1021%2Facs.chemrestox.4c00258&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-228X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-228X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-228X&client=summon